A new pancreatic cancer drug doubles survival times. And a new treatment for a rare form of ALS slows and improves some patients' symptoms.

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Former Senator Ben Sasse has become an unlikely public face of a drug that researchers are ...

New clinical trial data show KRAS-blocking drugs may significantly improve survival for the disease. “I think this is truly an earth-shattering moment in pancreatic cancer.” Daraxonrasib, an ...

Pancreatic adenocarcinoma remains one of the most aggressive and difficult-to-treat solid tumor malignancies, with a high mortality-to-incidence ratio. Globally, pancreatic cancer ranks 12th in terms ...

For decades, pancreatic cancer has been one of the most lethal cancers, with few effective treatment options. A new drug, daraxonrasib, targets the KRAS mutation that fuels most pancreatic ...

RAS oncoproteins, once considered undruggable, are now being successfully targeted by new drugs like daraxonrasib, showing dramatically improved survival in pancreatic cancer patients. Personalized ...

CLEVELAND — For patients with advanced pancreatic cancer who have run out of options, a targeted pill is offering something rare: more time. Pancreatic cancer is one of the most feared diagnoses in ...

“She was only 61 and very healthy,” said Allan Knight of his mother Judy, who was diagnosed and died of pancreatic cancer in 2007. “I did one search and the survival rates were in the single digits. I ...